Doxorubicin liposomal (2-BBB Medicines)

多柔比星脂质体 (2-BBB Medicines)

Report date: 2025/10/24 17:59:53

Base Information

Drug NameDoxorubicin liposomal (2-BBB Medicines)

Drug Alias NameDoxorubicin glutathione-pegylated liposome therapeuticGSH-PEG liposomal doxorubicin2B3-1012X-111

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Anthracycline antibiotics

Mechanisms of ActionDNA intercalatorsTopoisomerase II inhibitorsRNA synthesis inhibitors

TargetsDNATopoisomerase II

Therapy Area/IndicationsBrain metastasesGlioma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator Companies2-BBB Medicines BV

China Registration ClassN/A

Inactive CompaniesN/A

Active IndicationsBrain metastasesGlioma

Inactive IndicationsN/A

ATC CodeN/A